In summary, in addition to the possibility of therapeutically targeting HDAC, to what extent SCFAs selectively inhibit HDAC requires further investigation as another potential mechanism to manage obesity. This evidence concerns the gene HDAC9 and obesity due to melanocortin 4 receptor deficiency.